|
128 Companies |
|
121 Products |
|
121 Products |
|
104 Mechanisms of Action |
|
7 Trials |
|
1812 News |
|
| «12...1112131415161718192021...3637» |
- Trial initiation date, Trial primary completion date: NESP: Non-endoscopic EC Screening Program in Northern Iran (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=12000, Not yet recruiting, Sponsor: Tehran University of Medical Sciences
Initiation date: Feb 2015 --> Nov 2015 | Trial primary completion date: Dec 2016 --> Nov 2017
- | Trial completion: Open Versus Laparoscopically-assisted Esophagectomy for Cancer (clinicaltrials.gov) - Aug 14, 2015
P3, N=207, Completed, Sponsor: University Hospital, Lille
Initiation date: Feb 2015 --> Nov 2015 | Trial primary completion date: Dec 2016 --> Nov 2017 Active, not recruiting --> Completed
- oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg., everolimus / Generic mfg.
Trial primary completion date, Metastases: Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (clinicaltrials.gov) - Aug 14, 2015
P1/2, N=44, Active, not recruiting, Sponsor: City of Hope Medical Center
Active, not recruiting --> Completed Trial primary completion date: Nov 2015 --> Apr 2016
- |||| colesevelam (IW-3718) / Ironwood Pharma
Trial completion, Trial primary completion date: Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors (clinicaltrials.gov) - Aug 14, 2015
P2, N=93, Completed, Sponsor: Ironwood Pharmaceuticals, Inc.
Trial primary completion date: Nov 2015 --> Apr 2016 Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2014
- esomeprazole / Generic mfg.
Trial primary completion date: Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy (clinicaltrials.gov) - Aug 13, 2015
P4, N=500, Recruiting, Sponsor: Chang Gung Memorial Hospital
Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2014 Trial primary completion date: Jun 2015 --> Dec 2015
- Trial initiation date, Trial suspension, Metastases: ATTACK-OG: NY-ESO-1 T Cells in OG Cancer (clinicaltrials.gov) - Aug 13, 2015
P2, N=28, Suspended, Sponsor: Fiona Thistlethwaite
Trial primary completion date: Jun 2015 --> Dec 2015 Initiation date: Apr 2014 --> Oct 2014 | Not yet recruiting --> Suspended
- Enrollment change, Trial withdrawal, Trial primary completion date: Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma (clinicaltrials.gov) - Aug 13, 2015
P1, N=0, Withdrawn, Sponsor: Weill Medical College of Cornell University
Initiation date: Apr 2014 --> Oct 2014 | Not yet recruiting --> Suspended N=12 --> 0 | Terminated --> Withdrawn | Trial primary completion date: Jun 2013 --> Jun 2029
- Enrollment closed, Metastases: Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (clinicaltrials.gov) - Aug 12, 2015
P2, N=96, Active, not recruiting, Sponsor: Alliance for Clinical Trials in Oncology
N=12 --> 0 | Terminated --> Withdrawn | Trial primary completion date: Jun 2013 --> Jun 2029 Suspended --> Active, not recruiting
- modafinil / Generic mfg.
Trial completion, Trial primary completion date: Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia (clinicaltrials.gov) - Aug 12, 2015
P2, N=124, Completed, Sponsor: University of Arkansas
Suspended --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2015
- Enrollment change, Trial withdrawal: Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease (clinicaltrials.gov) - Aug 12, 2015
P3, N=0, Withdrawn, Sponsor: Eurofarma Laboratorios S.A.
Recruiting --> Completed | Trial primary completion date: May 2017 --> Aug 2015 N=292 --> 0 | Not yet recruiting --> Withdrawn
- esomeprazole / Generic mfg.
Enrollment change, Trial withdrawal, Head-to-Head: Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC (clinicaltrials.gov) - Aug 12, 2015
P3, N=0, Withdrawn, Sponsor: Eurofarma Laboratorios S.A.
N=292 --> 0 | Not yet recruiting --> Withdrawn N=188 --> 0 | Not yet recruiting --> Withdrawn
- esomeprazole / Generic mfg.
Trial completion: PHARO: Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=30, Completed, Sponsor: University Hospital, Bordeaux
N=188 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed
- ||| cabazitaxel / Generic mfg.
Enrollment closed, Trial primary completion date, Metastases: Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma (clinicaltrials.gov) - Aug 11, 2015
P2, N=86, Active, not recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Jun 2015
- New trial: POETA: Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia (clinicaltrials.gov) - Aug 10, 2015
P=N/A, N=400, Recruiting, Sponsor: Medical University of Vienna
- Enrollment open: Secondary Prophylaxis of Gastric Variceal Bleed (clinicaltrials.gov) - Aug 2, 2015
P=N/A, N=64, Recruiting, Sponsor: West China Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Jun 2015 Active, not recruiting --> Recruiting
- Phase classification, Enrollment change, Trial initiation date, Trial primary completion date: NUTRIENTII: Nutritional Route In Esophageal Resection Trial II (clinicaltrials.gov) - Jul 31, 2015
P=N/A, N=148, Not yet recruiting, Sponsor: Catharina Ziekenhuis Eindhoven
Active, not recruiting --> Recruiting Phase classification: P3 --> P=N/A | N=266 --> 148 | Initiation date: Apr 2015 --> Nov 2015 | Trial primary completion date: Dec 2016 --> Apr 2017
- New trial: Comparison of Outcomes Between Parenteral and Enteral Nutrition (clinicaltrials.gov) - Jul 30, 2015
P=N/A, N=5824, Completed, Sponsor: Tokyo University
- ||||| omeprazole / Generic mfg.
New P4 trial: The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease (clinicaltrials.gov) - Jul 22, 2015
P4, N=150, Recruiting, Sponsor: Torax Medical Incorporated
- | Enrollment open: TENSDEG: Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia (clinicaltrials.gov) - Jul 22, 2015
P3, N=118, Recruiting, Sponsor: University Hospital, Rouen
Phase classification: P3 --> P=N/A | N=266 --> 148 | Initiation date: Apr 2015 --> Nov 2015 | Trial primary completion date: Dec 2016 --> Apr 2017 Active, not recruiting --> Recruiting
- | carvedilol / Generic mfg.
New P4 trial: Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding (clinicaltrials.gov) - Jul 22, 2015
P4, N=120, Recruiting, Sponsor: Kaohsiung Veterans General Hospital.
- ||| esomeprazole / Generic mfg.
Clinical data, Enrollment open: Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes (clinicaltrials.gov) - Jul 21, 2015
P=N/A, N=1500, Recruiting, Sponsor: AstraZeneca
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion: Neuromuscular Electrical Stimulation (NMES) Treatment Technique Therapy in the Management of Young Infants With Severe Dysphagia (clinicaltrials.gov) - Jul 20, 2015
P2, N=10, Completed, Sponsor: The Hospital for Sick Children
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- New trial: NOSE: The Efficacy and Patient Tolerance of Ultrathin Nasal Endoscopy to Detect Barrett's Oesophagus (clinicaltrials.gov) - Jul 15, 2015
P=N/A, N=115, Completed, Sponsor: University of Cambridge
- New trial: Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung Carcinomas (clinicaltrials.gov) - Jul 14, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: University Medical Centre Groningen
- New trial: Oesophagix: Esophageal Atresia: Metaplasia, Barrett (clinicaltrials.gov) - Jul 13, 2015
P=N/A, N=120, Completed, Sponsor: University Hospital, Lille
- bortezomib / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Enrollment change, Combination therapy, Metastases: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction (clinicaltrials.gov) - Jul 13, 2015
P2, N=37, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Active, not recruiting --> Completed N=60 --> 37
- Trial primary completion date, HEOR: Quality of Life After Esophagectomy for Cancer - Step 2 (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=128, Recruiting, Sponsor: University of Padova
N=60 --> 37 Trial primary completion date: Jun 2015 --> Dec 2015
- Trial primary completion date, HEOR: Quality of Life After Esophagectomy for Cancer - Step 1 (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=128, Recruiting, Sponsor: University of Padova
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Jun 2015 --> Dec 2015
- sunitinib / Generic mfg.
Enrollment change, Metastases: Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction (clinicaltrials.gov) - Jul 10, 2015
P2, N=12, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Trial primary completion date: Jun 2015 --> Dec 2015 N=98 --> 12
- New trial: StrongVoice: Neurogenic Dysphonia/Dysphagia Registry (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=400, Recruiting, Sponsor: Merz Pharmaceuticals, LLC
- | New P2 trial: CIK in Treating Patients With Esophageal Cancer (clinicaltrials.gov) - Jul 8, 2015
P2, N=2000, Not yet recruiting, Sponsor: The First People's Hospital of Changzhou
- New trial: A Pilot Study of the Effectiveness of Acceptance and Commitment Therapy With a Post-Upper GI Cancer Population (clinicaltrials.gov) - Jul 8, 2015
P=N/A, N=50, Not yet recruiting, Sponsor: Martin Dempster
- | Gilotrif (afatinib) / Boehringer Ingelheim
Enrollment closed, Combination therapy, Metastases: Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment (clinicaltrials.gov) - Jul 2, 2015
P2, N=36, Active, not recruiting, Sponsor: Columbia University
N=98 --> 12 Recruiting --> Active, not recruiting
- ||| Trial completion, Enrollment change: Effects of Diet on Reflux and Dyspepsia (clinicaltrials.gov) - Jun 29, 2015
P=N/A, N=84, Completed, Sponsor: University of Zurich
Recruiting --> Active, not recruiting Enrolling by invitation --> Completed | N=120 --> 84
- Trial primary completion date: Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)? (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=20, Enrolling by invitation, Sponsor: Mayo Clinic
Enrolling by invitation --> Completed | N=120 --> 84 Trial primary completion date: May 2015 --> Dec 2015
- ||| New trial: The Captivator EMR Registry (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=300, Not yet recruiting, Sponsor: Boston Scientific Corporation
- Trial primary completion date: Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=650, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: May 2015 --> Dec 2015 Trial primary completion date: Nov 2016 --> Nov 2017
- Enrollment closed, Surgery: The Effect of Chemotherapy and Surgery for Cancer on Exercise Capacity (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=253, Active, not recruiting, Sponsor: Aintree University Hospitals NHS Foundation Trust
Trial primary completion date: Nov 2016 --> Nov 2017 Recruiting --> Active, not recruiting
- Folotyn (pralatrexate) / Aurobindo
Trial primary completion date, Combination therapy, Metastases: Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer (clinicaltrials.gov) - Jun 25, 2015
P2, N=35, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2015 --> Jan 2015
- || bupropion / Generic mfg.
Trial primary completion date: Bupropion in Helping Adults Stop Smoking (clinicaltrials.gov) - Jun 23, 2015
P2, N=97, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
Trial primary completion date: Jun 2015 --> Jan 2015 Trial primary completion date: May 2009 --> May 2008
- ||| AMG 337 / ImmunityBio, Amgen
Enrollment closed, Enrollment change: Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors (clinicaltrials.gov) - Jun 23, 2015
P2, N=60, Active, not recruiting, Sponsor: Amgen
Trial primary completion date: May 2009 --> May 2008 Recruiting --> Active, not recruiting | N=140 --> 60
- ||| esomeprazole / Generic mfg.
Clinical data, New trial: Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes (clinicaltrials.gov) - Jun 22, 2015
P=N/A, N=1500, Not yet recruiting, Sponsor: AstraZeneca
- || Trial primary completion date: Acceptability of Less Harmful Alternatives to Cigarettes (clinicaltrials.gov) - Jun 22, 2015
P=N/A, N=67, Completed, Sponsor: Roswell Park Cancer Institute
Recruiting --> Active, not recruiting | N=140 --> 60 Trial primary completion date: Nov 2009 --> Aug 2009
- Enrollment change: Enhancing Detection of Small Esophageal Varices by PillCam ESO (clinicaltrials.gov) - Jun 20, 2015
P3, N=0, Withdrawn, Sponsor: Medical College of Wisconsin
Trial primary completion date: Nov 2009 --> Aug 2009 N=50 --> 0
- Enrollment change: Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers (clinicaltrials.gov) - Jun 20, 2015
P=N/A, N=0, Withdrawn, Sponsor: University of California, Davis
N=50 --> 0 N=20 --> 0
- New trial: Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders (clinicaltrials.gov) - Jun 20, 2015
P=N/A, N=60, Recruiting, Sponsor: University of Alabama at Birmingham
- | New P4 trial: Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke (clinicaltrials.gov) - Jun 16, 2015
P4, N=70, Recruiting, Sponsor: Parc de Salut Mar
- Trial primary completion date: Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=20, Recruiting, Sponsor: Showa Inan General Hospital
N=20 --> 0 Trial primary completion date: Mar 2015 --> Mar 2016
- Trial primary completion date: Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=50, Recruiting, Sponsor: University of Miami
Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Apr 2015 --> Apr 2017
- Trial primary completion date: RCT of Stent Versus Standard Therapy in Oesophageal Variceal Haemorrhage (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=136, Recruiting, Sponsor: University College, London
Trial primary completion date: Apr 2015 --> Apr 2017 Trial primary completion date: Feb 2014 --> Aug 2015